搜尋
Cyclerion Therapeutics Inc
CYCN添加自選
3.380USD
-0.010-0.29%
收盤 06/30, 16:00（美東）報價延遲15分鐘
12.92M總市值
虧損本益比TTM
關於 Cyclerion Therapeutics Inc 公司
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.
Cyclerion Therapeutics Inc簡介
公司代碼CYCN
公司名稱Cyclerion Therapeutics Inc
上市日期Mar 18, 2019
CEOGraul (Regina M)
員工數量1
證券類型Ordinary Share
年結日Mar 18
公司地址301 Binney Street
城市CAMBRIDGE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編02142
電話16176217722
網址https://www.cyclerion.com/
公司代碼CYCN
上市日期Mar 18, 2019
CEOGraul (Regina M)
Cyclerion Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Rhonda M. Chicko
Ms. Rhonda M. Chicko
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
常見問題
Cyclerion Therapeutics Inc的前五大股東是誰？
Cyclerion Therapeutics Inc的前五大股東如下：Dr. Peter M. Hecht, Ph.D.
有多少機構持有Cyclerion Therapeutics Inc(CYCN)的股份？
截至2026Q1，共有37家機構持有Cyclerion Therapeutics Inc的股份，合計持有的股份價值約為318.08K，占公司總股份的7.35% 。與2025Q4相比，機構持股有所增加，增幅為-667233.00。